心脏手术后谵妄患者的蛋白质改变:VISION心脏手术生物样本库的探索性病例对照子研究
该研究为VISION心脏手术生物样本库的探索性病例对照子研究,匹配30例术后第1天谵妄患者与30例对照,用Olink Explore 3K平台检测术后第3天血液蛋白质。发现26种蛋白质与谵妄显著相关(均升高),包括FKBP1B、C2CD2L、RAB6B和白细胞介素-8,未发现神经炎症或脑损伤标志物关联。
要点
- 心脏术后谵妄患者术后第3天有26种血清蛋白显著升高。
- 差异最显著的蛋白为FKBP1B、C2CD2L和RAB6B。
- 未发现谵妄与已知神经炎症或脑损伤蛋白相关。
核心结论
- 发现26种与心脏术后谵妄显著相关的血清蛋白,除白细胞介素-8外均为新发现。
- 未发现谵妄与公认的神经炎症蛋白或脑损伤标志物关联,支持用生物标志物鉴别谵妄与其他神经系统疾病。
研究设计与样本
- 探索性病例对照子研究,样本来自VISION心脏手术生物样本库。
- 纳入30例术后第1天谵妄患者,按年龄、性别、 ethnicity、中心和体外循环时间匹配30例对照。
- 使用Olink Explore 3K平台检测术后第3天血液蛋白质,浓度以归一化蛋白表达单位(log2倍数尺度)表示。
主要发现
- 在2865种独特血清蛋白中,26种(0.9%)与谵妄状态显著相关,均在病例组升高(FDR<0.05)。
- 通路分析显示钙释放通道活性(Padj=0.02)和GTP结合功能(Padj=0.005)为谵妄相关蛋白的特征。
- 差异表达最显著的三种生物标志物为FKBP1B(Padj=0.003)、C2CD2L(Padj=0.004)和RAB6B(Padj=0.004)。
- 炎症生物标志物白细胞介素-8(CXCL8;平均差=2.36;P=3.6×10^-4)也与谵妄相关。
关键数值与推荐
- 蛋白质表达比较采用配对t检验,基于FDR校正P值小于0.05判定显著差异。
临床怎么用
- 研究为探索性,结果支持未来研究验证这些候选生物标志物用于诊断术后谵妄。
- 支持使用无偏筛选方法识别潜在的谵妄生物标志物。
局限性
- 研究为探索性病例对照子研究,样本量小(30对匹配),需未来研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delirium is an acute state of confusion associated with adverse postoperative outcomes. Delirium is diagnosed clinically using screening tools; most cases go undetected. Identifying a delirium biomarker would allow for accurate diagnosis, application of therapies, and insight into causal pathways. To agnostically discover novel biomarkers of delirium, a case-control substudy was conducted using the Vascular Events in Surgery Patients Cohort Evaluation (VISION) Cardiac Surgery Biobank. The objective was to identify candidate biomarkers to investigate in future studies. METHODS: The study gathered a convenience sample of 30 patients with delirium on postoperative day 1 matched to 30 controls by age, sex, ethnicity, center, and cardiopulmonary bypass time. The Olink Explore 3K platform was used to identify blood protein alterations on postoperative day 3. Protein concentrations were expressed as normalized protein expression units (log 2 fold scale). Protein expression was compared between cases and controls using a paired t test and identified significantly different biomarkers based on a false discovery rate-adjusted P value of less than 0.05. RESULTS: Of 2,865 unique serum proteins, 26 (0.9%) were significantly associated with delirium status; all were elevated in cases versus controls at a false discovery rate of less than 0.05. Pathway analysis identified calcium-release channel activity ( Padj = 0.02) and GTP-binding ( Padj = 0.005) functions as characteristic of proteins associated with delirium. The top three differentially expressed biomarkers were FKBP1B ( Padj = 0.003), C2CD2L ( Padj = 0.004), and RAB6B ( Padj = 0.004). The inflammatory biomarker interleukin-8 (CXCL8; mean difference = 2.36; P = 3.6 × 10- 4 ) was also associated with delirium. CONCLUSIONS: The study identified 26 biomarkers significantly associated with delirium; all are novel except for interleukin-8. An association between delirium and recognized neuroinflammatory proteins or markers of brain injury was not identifed, which supports using biomarkers to differentiate between delirium and other neurologic conditions. While exploratory, the study's findings support using biomarkers to diagnose postoperative delirium and validate using agnostic screens to identify potential delirium biomarkers.
引用
- Spence J, Devereaux PJ, Bashir S, et al. Protein Alterations in Patients with Delirium after Cardiac Surgery: An Exploratory Case-Control Substudy of the VISION Cardiac Surgery Biobank. Anesthesiology. 2025. PMID: 39786937. doi:10.1097/ALN.0000000000005368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。